KRIBIOLISA™ Semaglutide ELISA

GLP-1 receptor agonist medicines, also called incretin mimetics, are a type of incretin-based medicine for type 2 diabetes that control pancreatic function. These medicines (Exenatide, Semaglutide, Lixisenatide, and Liraglutide) copy, or mimic, the action of GLP-1 made by your body.

Krishgen’s range of ELISA for GLP-1 agonists can be used for pharmacokinetic studies, including dosage regimen and therapy development.

About the Semaglutide assay:

• Uses highly specific antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity
• Recovery rates are 80 - 120%
• Validated as per US FDA guidelines for Bioassays
• Optimized for matrix effects to ensure higher sensitivity
• Uses the innovator drug as calibrator, and is optimized for biosimilars studies
• Calibrator Range: 0 ng/ml-3000 ng/ml
• Sensitivity: 50 ng/ml
• Sample Type: serum and plasma
• Reactivity: Human
• Shipping Condition: 2 - 8 Deg C
• Detection Method: Colorimetric
• Usage: For Research Use Only
• Research Area: Diabetes